<?xml version="1.0" encoding="UTF-8"?>
<ref id="B28-viruses-11-01064">
 <label>28.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Xie</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Liu</surname>
    <given-names>J.H.</given-names>
   </name>
   <name>
    <surname>Liu</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Liao</surname>
    <given-names>X.Z.</given-names>
   </name>
   <name>
    <surname>Chen</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Lin</surname>
    <given-names>M.G.</given-names>
   </name>
   <name>
    <surname>Gu</surname>
    <given-names>Y.Y.</given-names>
   </name>
   <name>
    <surname>Liu</surname>
    <given-names>T.L.</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>D.M.</given-names>
   </name>
   <name>
    <surname>Ge</surname>
    <given-names>H.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Tanshinone IIA combined with adriamycin inhibited malignant biological behaviors of NSCLC A549 cell line in a synergistic way</article-title>
  <source>BMC Cancer</source>
  <year>2016</year>
  <volume>16</volume>
  <elocation-id>899</elocation-id>
  <pub-id pub-id-type="doi">10.1186/s12885-016-2921-x</pub-id>
  <pub-id pub-id-type="pmid">27863471</pub-id>
 </element-citation>
</ref>
